Oxysterols are bioactive metabolites of cholesterol and of its precursors. Although they are known to be present in brain their distribution in brain is poorly defined. The current study describes the exploitation of on-tissue enzyme-assisted derivatisation with micro-liquid-extraction for surface analysis and nano-liquid chromatography -mass spectrometry for the imaging of oxysterols in tissue slices (10 µm) of mouse brain. 24S-Hydroxycholesterol (24S-HC), derived from cholesterol through oxidation by the enzyme CYP46A1, was found to be the most abundant oxysterol in all brain regions, being at highest areal density in striatum (1.71 ± 0.27 ng/mm 2 , mean ± SD, n = 3 animals) and in thalamus (1.75 ± 0.45 ng/mm 2 ) and at lowest levels in the grey matter of the cerebellum (0.18 ± 0.06 ng/mm 2 ). The combined presence of acidic sterols, 3β,7α-dihydroxycholest-5-en-(25R)26-oic and 7αhydroxy-3-oxocholest-4-en-(25R)26-oic acid, was defined in all regions being most abundant in grey matter of cerebellum (0.02 ± 0.01 ng/mm 2 ), while 7-oxocholesterol was ubiquitously present at low levels (<0.01 ng/mm 2 ). By analysis of brain tissue of the Cyp46a1 knockout mouse we confirmed the almost complete absence of 24S-HC and we are able to detect other oxysterols including 24Rhydroxycholesterol, which is most abundant in white matter of the cerebellum (0.02 ± 0.00 ng/mm 2 ), 25-hydroxycholesterol and the elusive 20S-hydroxycholesterol.
Introduction
Oxysterols are oxidised forms of cholesterol or of its precursors [Shroepfer 2000 ]. They are intermediates in steroid hormone and bile acid biosynthesis and possess diverse biological properties [Bjorkhem 2013 , Luu 2016 . One of the most well studied oxysterols is . In mammals it is mostly synthesised in neurons by the enzyme cytochrome P450 (CYP) 46A1 and acts as a transport form of cholesterol (Supplemental Figure S1 ) [Lund 1999 , Bjorkhem 2006 , Russell 2009 ]. Unlike cholesterol, 24S-HC can cross the blood brain barrier (BBB). 24S-HC is a ligand to the liver X receptors (LXRs) [Lehmann 1997 ], the β-form of which is highly expressed in brain [Wang 2002 ], a potent modulator of the N-methyl-D-aspartate receptors (NMDARs), glutamate-gated ion channels that are critical to the regulation of excitatory synaptic function in the central nervous system (CNS) [Paul 2013] , and is also a modulator of cholesterol biosynthesis by interacting with the endoplasmic reticulum protein INSIG (insulin induced gene) and restricting transport and processing of SREBP-2 (sterol regulatory element-binding protein-2) to its active form as a master transcription factor for cholesterol biosynthesis [Radhakrishnan 2007 , Wang 2008 . Despite its potent biological activity, little is known about levels of 24S-HC in distinct regions of brain [Heverin 2004 , Mast 2017a . This is also true of the cholestenoic acids, 3β,7α-dihydroxycholest-5-en-(25R)26-oic (3β,7α-diHCA) and 7α-hydroxy-3-oxocholest-4-en-(25R)26-oic (7αH,3O-CA) acids, also formed by enzymatic oxidation of cholesterol, and found in cerebrospinal fluid (CSF), the fluid that bathes the CNS [Theofilopoulos 2014 , Saeed 2014 . 7αH,3O-CA has been suggested to provide an export route for (25R)26-hydroxycholesterol (26-HC, cholest-5-ene-3β,(25R)26-diol also called 27hydroxycholesterol) which itself passes into the brain from the circulation, but does not accumulate in brain (see Supplemental Figure S1 ) [Heverin 2005 , Meaney 2007 ]. 3β,7α-diHCA has been shown to be biologically active as a ligand to the LXRs and to be protective towards oculomotor neurons [Theofilopoulos 2014 ]. The location of neither acid has previously been defined in brain [Griffiths 2019 ].
The CNS represents a major repository of unesterified cholesterol in mammals, almost 25% of total body cholesterol is found in the CNS where it is present at a level of about 20 µg/mg (wet weight) [Dietschy 2004 ]. Much of that cholesterol is found in myelin sheaths of oligodendrocytes surrounding the axons of neurons, where it is turned over slowly (0.4%/day in mouse, 0.03% in human [Dietschy 2004]) . A more metabolically active pool of cholesterol is located in intracellular structures such as the endoplasmic reticulum, Golgi apparatus and nucleus of neurons. Here turn-over is estimated at 20% per day in mouse [Dietschy 2004 ]. As cholesterol cannot cross the BBB essentially all cholesterol in brain is biosynthesised in brain. Inborn errors of cholesterol biosynthesis can result in neurodevelopmental disorders and retardation syndromes [Kanugo 2013 ].
Although cholesterol is the major source of oxysterols, its precursors can also be a source of these molecules [Javitt 2004 . In fact, some cholesterol precursors have biological activity in their own right [Muse 2018 ]. Desmosterol (cholesta-5,24-dien-3β-ol) , the immediate precursor of cholesterol in the Bloch arm of the cholesterol biosynthetic pathway, is both a ligand to the LXRs and also supresses SREBP-2 processing to its active form [Yang 2006 , Radhakrishnan 2007 . While levels of cholesterol, desmosterol and other cholesterol precursors have been measured in brain homogenates, fewer studies have been performed to localise these sterols to distinct brain regions [Heverin 2004 , Mast 2017a ].
To understand better the importance in brain of sterols in general, and oxysterols in particular, it is necessary to correlate molecular concentrations with histology. This can be done by microdissection followed by homogenisation and sterol analysis by mass spectrometry (MS) [Heverin 2004 , Mast 2017a ]. However, with small laboratory animals this is not a simple task. An alternative method to map sterol concentrations in brain is by exploiting mass spectrometry imaging (MSI). This technology pioneered for biological applications by Caprioli and colleagues in the USA [Norris 2013] and Spengler and colleagues in Europe [Spengler 2015] , exploiting matrix-assisted laser desorption/ionisation (MALDI), has been widely used to image proteins, peptides and lipids in tissues , Gessel 2014 . MALDI-MSI has been used to image lipids in brain [Trim 2008 , Zemski Berry 2014 , however, cholesterol and other sterols tend to be poorly ionised by conventional MALDI and are underrepresented in MALDI-MSI studies. To enhance ionisation other desorption methods have been employed, including nanostructure-initiator MS [Patti 2010 ], sputtered silver-MALDI [Xu 2015] and silver nanoparticle-MALDI [Roux 2016 , Muller 2017 . Silver ions co-ordinate with carbon-carbon double bonds providing cationic adducts of sterols in the MALDI matrix.
MALDI-MSI has been used to image steroid hormones and steroidal drugs in tissue. To achieve this, researchers have utilised on-tissue derivatisation exploiting hydrazine reactions with carbonyl groups present in target analytes (e.g. Figure 1A ) [Cobice 2013 , Flinders 2015 , Barré 2016 , Shimma 2016 ]. Similar reactions have been utilised in "reactive-DESI" (desorption electrospray ionisation), an alternative ionisation technique that can be used for MSI [Badu-Tawiah 2012] . Ontissue derivatisation has also been used in combination with "liquid extraction for surface analysis" (LESA) technology [Cobice 2013 [Cobice , 2016 [Cobice , 2018 , which is based on liquid micro-junction surface sampling [Van Berkel 2008] , where solvent is deposited as a small volume droplet by a robotic sampling probe, i.e. pipette tip or capillary, onto a surface, aspirated back to the tip or capillary and the extract analysed by electrospray ionisation (ESI)-MS. For lipid analysis, the high organic content of the solvent can lead to solvent spreading and low spatial resolution. To minimise this, the sampling probe can be used to make a seal against the tissue surface, thereby preventing solvent spreading and minimising spot size (400 µm diameter) [Almeida 2015 ]. The advantage of on-tissue derivatisation in combination with LESA is that low abundance, or poorly ionised lipids i.e. steroids and oxysterols, can be targeted through derivatisation, allowing the observation of otherwise undetectable molecules, also giving sufficiently abundant ions for multi-stage fragmentation (MS n ) [Cobice 2013 ]. Cobice et al using a combination of on-tissue derivatisation, MALDI-MSI and LESA-MS 2 have monitored the distribution of corticosteroid in mouse brain tissue and confirmed 7-oxocholesterol (7-OC, 3β-hydroxycholest-5-en-7-one, also called 7-ketocholesterol) as a substrate for the enzyme 11β-hydroxysteroid dehydrogenase 1 (HSD11B1) and detected testosterone and 5α-dihydrotestosterone in mouse testis [Cobice 2013 [Cobice , 2016 ].
On-tissue derivatisation is problematic for sterols, oxysterols or steroids not possessing a carbonyl group. The hydroxy group can be targeted for derivatisation but this group is common to a wide range of biomolecules and this strategy provides little selectivity. An alternative approach, exploited for insolution oxysterol analysis, is to utilise a bacterial cholesterol oxidase enzyme to specifically convert sterols with a 3β-hydroxy-5-ene or 3β-hydroxy-5α-hydrogen structure to 3-oxo-4-ene or 3-oxo-5αsterols and then derivatise the 3-oxo group with the Girard hydrazine reagent to provide a charge-tag to the target molecule ( Figure 1C ) [Karu 2007 . This strategy is termed enzyme-assisted derivatisation for sterol analysis (EADSA). Oxysterols naturally possessing an oxo group, e.g. 7αH,3O-CA or 7-OC, can be derivatised in parallel in the absence of cholesterol oxidase. A challenge in oxysterol and sterol analysis is that the dominant sterol in mammals is cholesterol, usually being about a thousand-fold more abundant than other sterols or oxysterols. Thus, in the absence of chromatography, EADSA mass spectra are dominated by cholesterol. In the current study we describe how we have exploited on-tissue EADSA with micro-scale-LESA (µLESA) and nano-liquid chromatography (nano-LC) -MS(MS n ) for the imaging of oxysterols in rodent brain. We find 24S-HC to be the most abundant oxysterol in all brain regions, being at highest levels in striatum and thalamus and at lowest levels in grey matter of cerebellum. We are also able to definitively identify 3β,7α-diHCA in brain, where it is most abundant in cerebellum. We confirm that 24S-HC is almost completely absent from brain of the Cyp46a1 knockout mouse (Cyp46a1-/-), but low levels of 20S-hydroxycholesterol (20S-HC, cholest-5-ene-3β,20S-diol), 22R-hydroxycholesterol (cholest-5-ene-3β,22R-diol), 24Rhydroxycholesterol (24R-HC, cholest-5-ene-3β,24R-diol) and are present in this mouse.
Results

Analytical Platform
The platform was designed to allow the MSI of oxysterols in tissue against a large background of cholesterol and other more readily ionised lipids. To meet this challenge, we have used on-tissue derivatisation ( Figure 1 ) in combination with µLESA and nano-LC-MS(MS n ). Each of the system components required optimisation as described below.
On-Tissue EADSA
The protocol for on-tissue enzymatic oxidation of sterols ( Figure 1 ) was adapted from the in-solution procedure using cholesterol oxidase enzyme in KH2PO4 buffer [Karu 2007 , the only difference being that the enzyme was sprayed onto tissue in buffer and then incubated at 37 o C in a humid chamber (11.9 cm x 8.2 cm x 8.5 cm, 30 mL water) rather than being in solution. In trial experiments, after a 1 hr incubation period at 37 o C there was no evidence for any non-oxidised sterol, only the 3-oxo-4-ene (see Supplemental Results 1.2.1.). The next step in the method was on-tissue derivatisation of oxo-containing sterols ( Figure 1 ). Others have used Girard T (GT) hydrazine as the derivatising agent to react on-tissue with oxo-containing sterols/steroids [Cobice 2013 , Flinders 2015 , Barré 2016 , Shimma 2016 , however, based on our experience of using the Girard P (GP) reagent for in-solution derivatisation of oxysterols, GP hydrazine was preferred here [Karu 2007 . A disadvantage of using GT hydrazine is that a major MS 2 fragment-ion is the [M-59] + species ( Figure 1A ) and the exact same neutral-loss is observed in the fragmentation of endogenous phosphocholine-containing lipids. With [ 2 H0]GP the major MS 2 fragment-ion is [M-79] + and for [ 2 H5]GP [M-84] + , neutral-losses not common for other lipids. We sprayed GP reagent (6.3 mg/mL for [ 2 H5]GP bromide or 5 mg/mL [ 2 H0]GP chloride) in the same solvent as previously used for in-solution derivatisation (70% methanol 5% acetic acid) [Karu 2007 . As in reported studies using the GT reagent [Cobice 2013 , Barre 2016 , it was essential to incubate the GP-coated tissue in a humid atmosphere to achieve efficient derivatisation. Initial tests in a dry atmosphere revealed no derivatisation of 3-oxo-4-ene substrates. Incubation in a humid chamber (12 cm x 12 cm x 7.2 cm) containing 30 mL of 50% methanol, 5% acetic acid at 37ᵒC for 1 hr provided an efficient derivatisation environment with minimum lateral dispersion of analytes (see Supplemental Results 1.2.2. & 1.2.3 and Supplemental Figure S2 ). Increasing the volume or organic content of solution lead to lipid delocalisation, while reducing the volume and organic content provided less efficient derivatisation based on ion-current in µLESA-MS measurements. For comparison, Cobice et al sprayed GT hydrazine at 5 mg/mL in 80% methanol 0.1% trifluoroacetic acid and incubated in a sealed Petri dish containing 2 mL of water or in a sealed slide box at 80% humidity, for 60 min at 40 o C [Cobice et al 2013 [Cobice et al , 2016 .
µLESA
Using conventional LESA, a pipette tip is positioned above the target surface and dispenses a µLvolume of extraction solvent to create a liquid micro-junction with the surface [Parson 2012] . After a sufficient time has elapsed for surface-liquid analyte extraction, solvent is then aspirated back to the tip. The pipette tip containing extract is then robotically transferred to a nano-ESI chip for MS analysis. Spot size using this format is typically >1 mm in diameter. The LESA PLUS configuration of the TriVersa Nanomate incorporates a 200 µm i.d. / 360 µm o.d. fused silica capillary replacing the pipette tip and when used with water-rich extraction solvents can improve spot size to <1 mm [Lamont 2017 , Ryan 2018 . However, when using a 50% methanol solvent, as required here for extraction of derivatised sterols, we were unable to achieve this spot size as the surface tension required for a stable liquid micro-junction was not attainable. To overcome this problem, a 330 µm i.d. / 794 µm o.d. FEP (fluorinated ethylene propylene) sleeve was attached to the fused silica capillary and used to make a direct seal with the tissue surface preventing spreading of the extraction solvent beyond the boundary of the sleeve (Supplemental Figure S3A ). This gave a spot size of diameter <400 µm, as assessed by microscopic evaluation of tissue after liquid extraction (Supplemental Figure S3B ). A 50% methanol extraction solvent was chosen to closely match the derivatisation solvent and loading phase used for the nano-LC injections (see below). The volume of solvent dispensed onto (more correctly, in contact with) tissue was optimised to maximise oxysterol extraction with an extraction time of 30 s, as assessed by MS ion-current for target oxysterols (e.g. 24S-HC), without compromising spatial resolution i.e. leaking of solvent through the tissue -FEP seal. The number of repeat extractions on the same spot was similarly optimised. The optimal conditions were a "dispensed volume" of 1 µL, an extraction time of 30 s, performed three times on the same spot.
Alternatively, Almeida et al have used LESA with a pipette tip to make a direct seal on-tissue for liquid extraction of lipids with organic solvents. They achieved a spot size of diameter 400 µm and directly analysed the extract by nano-ESI. Their extraction volume was 0.5 µL and extraction time 30 s [Almeida 2015 ].
Nano-LC
The nano-LC system was based on the reversed-phase LC system routinely used for oxysterol analysis after EADSA [Karu 2007 and modified by Roberg-Larsen et al for nano-LC [Roberg-Larsen 2014]. By incorporating a reversed-phase trap column prior to the analytical column it was possible to trap GP-derivatised sterols and wash to waste unreacted GP reagent and polar analytes ( Figure 2 ). After extraction of derivatised sterols by µLESA, loading on the trap column, and following a 13 min washing period, the trap column was back-flushed to the C18 analytical column. The gradient was optimised for analysis of oxysterols in brain allowing separation of the major oxysterol, 24S-HC, from the major sterol, cholesterol and its precursors desmosterol (cholesta-5,24-dien-3β-ol) and 7dehydrocholesterol (7-DHC, cholesta-5,7-dien-3β-ol). To avoid cross-contamination between samples a column wash with an injection of 10 µL of 100% propan-2-ol and a fast gradient was performed between injection of samples. Carry-over into this wash for 24S-HC and cholesterol was <2%. This procedure eliminated carry-over of oxysterols into the next sample. The relative standard deviation of retention-time for 24S-HC was 0.3% ± 0.1% (mean ± SD) over five successive injections of derivatised brain tissue.
24S-HC in Wild Type (WT) Mouse Brain
Previous studies using MS have defined concentrations of 24S-HC, the major oxysterol in mouse brain, to be of the order of 20 -60 ng/mg (wet weight) [Ogundare 2010 , Griffiths 2019 , Mast 2017b . For comparison, the concentration of cholesterol is in the range of 10 -20 µg/mg [Dietschy 2004 , Griffiths 2019 , and after EADSA treatment, in the absence of chromatographic separation, cholesterol totally dominates the µLEASA-MS analysis of the mouse brain extract ( Figure  3A ). However, with the addition of nano-LC to give the µLESA-nano-LC-MS format, analysis of 400 µm diameter spot extracts of brain tissue give clear peaks for 24S-HC in reconstructed ion chromatograms (RICs) for the appropriate [M] + ion at m/z 539.4368 ± 10 ppm ( Figure 3B , upper panel), in total ion chromatograms (TICs) for the transition 539.4→455.4→ (see Supplemental Figure S4B ) and in the characteristic multiple-reaction monitoring (MRM) chromatograms 539.4→455.4→353.3 ( Figure 3C , upper panel). The chromatographic peak doublet eluting at 27.57/28.36 in Figure 3B was confirmed to correspond to 24S-HC by exact mass measurement ( Figure 3D ) and from MS 3 ([M] + →[M-Py] + →) spectra ( Figure 3E ). The doublet is a consequence of syn and anti conformers of the GP-derivative. Relative quantification between spots was achieved using [ 2 H7]24R/S-HC standard (central panels in Figures 3B & C) sprayed on-tissue to an areal density of 1 ng/mm 2 (see below and Supplemental Methods 2.1.1).
EADSA-µLESA-nano-LC-MS
To assess the reproducibility of the EADSA-µLESA-nano-LC-MS technology six adjacent spots in the isocortical region of a single slice of mouse brain were analysed. The mean value of the peak area ratio 24S-HC : [ 2 H7]24R/S-HC was 0.95 with a relative standard deviation of 8 %. This corresponds to an areal density of 24S-HC of 0.95 ± 0.08 ng/mm 2 (mean ± SD). Assuming that the endogenous concentration of 24S-HC did not vary across the six adjacent spots the reproducibility of the method is satisfactory. The reproducibility of the method was further assessed by analysing nine regions of interest from four closely cut slices from a single brain. The relative standard deviation for areal density in each individual region varied from 12.4 % for the striatum where the areal density of 24S-HC was high (1.41 ± 0.18 ng/mm 2 , n = 4) to 46.3 % in the white matter of the cerebellum where the areal density of 24S-HC was low (0.19 ± 0.09 ng/mm 2 , n = 4, Figure 4A ).
The validity of using sprayed-on [ 2 H7]24R/S-HC as an internal standard for quantification of oxysterols was assessed by spraying increasing concentration ratios of [ 2 H7]24R/S-HC : [ 2 H7]22S-HC onto six successive slices of brain tissue. A plot of average peak area ratio of [ 2 H7]24R/S-HC : [ 2 H7]22S-HC for three closely arranged spots from the same isocortical region on each slice, against spraying concentration of [ 2 H7]24R/S-HC, keeping the concentration of [ 2 H7]22S-HC constant, gave a straight line with R 2 > 0.999 (Supplemental Figure S5A ). When this experiment was repeated but by plotting the average peak area ratio of [ 2 H7]24R/S-HC : 24S-HC, where 24S-HC refers to the endogenous molecule, against spraying concentration of [ 2 H7]24R/S-HC for closely arranged spots (n = 3) in the same region of interest on six successive slices, the result was a straight line of R 2 > 0.992 (Supplemental Figure S5B ). Assuming the concentration of endogenous 24S-HC does not vary across the six slices investigated in this study, or within the same region of interest, the results indicate that [ 2 H7]24R/S-HC can be used as a reliable internal standard for quantification of endogenous 24S-HC.
Oxysterol in Different Regions of WT Mouse Brain
Nine brain regions of interest, i.e. isocortex, striatum, thalamus, hippocampus, midbrain, pons, medulla, cerebellum (grey matter) and cerebellum (white matter), were analysed by µLESA-nano-LC-MS ( Figure 4 ).
24S-HC
As is evident from Figures 4 & 5, 24S-HC is least abundant in the grey and white matter of the cerebellum (0.183 ± 0.063 ng/mm 2 and 0.234±0.073 ng/mm 2 respectively, n = 3 biological replicates, see also Supplemental Table S1 ) and most abundant in the striatum (1.711 ± 0.273 ng/mm 2 ) and thalamus (1.752 ± 0.449 ng/mm 2 ).
3β,7α-diHCA, 7αH,3O-CA and 7-OC
Previous studies have suggested that 26-HC is imported into brain and converted in brain by a combination of enzymes, CYP27A1, CYP7B1 and HSD3B7 to 3β,7α-diHCA and 7αH,3O-CA (Supplemental Figure S1 ) [Heverin 2005 , Meaney 2007 , Theofilopoulos 2014 . We thus generated RICs and TICs for the appropriate [M] + ion, m/z 569.4110 ± 10 ppm, and MS 3 transition [M] + →[M-Py] + →, i.e. 569.4→485.3→, for the acids ( Figure S6A ). When using EADSA with cholesterol oxidase the combination of the sterol acids with a 3β-hydroxy-5-ene i.e. 3β,7α-diHCA and native 3oxo-4-ene structure i.e. 7αH,3O-CA is measured. The levels of the individual analytes are deconvoluted by repeat analysis on an adjacent section of brain tissue but in the absence of cholesterol oxidase enzyme using [ 2 H7]22S-HCO internal standard and [ 2 H0]GP reagent (Supplemental Figure S7 ), in which case 7αH,3O-CA is measured but not 3β,7α-diHCA. However, when at low levels, the combined areal densities of 3β,7α-diHCA and 7αH,3O-CA can be measured more accurately than either of the individual species. The combination of 3β,7α-diHCA plus 7αH,3O-CA was evident at areal densities of 0.002 ± 0.002 -0.018 ± 0.009 ng/mm 2 across the different regions of interest in mouse brain (see supplemental Table S1 ). In the absence of cholesterol oxidase treatment 7αH,3O-CA was detected in only some analysis at very low levels (0.001 ± 0.001 -0.003 ± 0.001ng/mm 2 ) leading to values for the deconvoluted acid (3β,7α-diHCA) in the range of 0.00 ± 0.00 -0.02 ± 0.01 ng/mm 2 . For each of the individual brains analysed the combined acids and deconvoluted acids were most abundant in the grey matter of the cerebellum ( Figure 5B and Supplemental Figure S8 ). For the three biological replicates the combined acids were found to be significantly (P<0.05) most abundant in the grey matter of the cerebellum ( Figure 5B , see also supplemental Table S2 ).
7-OC can be formed from 7-DHC in a CYP7A1 catalysed reaction [Shinkyo 2011], or alternatively from cholesterol via free radical mediated reactions [Murphy 2008] . GP reagent will react with 7-OC in the absence of added cholesterol oxidase ( Figure 1B ). It is distributed ubiquitously across the brain at low levels (0.002 ± 0.002 -0.004 ± 0.006 ng/mm 2 ). 7O-C has previously been detected in brain using Girard derivatisation and LESA-MS [Cobice 2013 ].
Oxysterols in Cyp46a1-/-Mouse Brain
24S-HC, 24R-HC, 20S-HC and 12α-HC
In the WT mouse, the high areal density of 24S-HC (0.183 ± 0.063 -1.752 ± 0.449 ng/mm 2 ) compared to other oxysterols makes the identification of any minor (<0.01 ng/mm 2 ) or closely eluting oxysterols difficult. To overcome this problem, we have taken advantage of brain tissue from the Cyp46a1-/mouse which is reported to be almost completely devoid to 24S-HC [Lund 2003 , Mast 2017b ]. Analysis of the same brain regions as for WT mouse confirmed an almost complete absence of 24S-HC in the Cyp46a1-/-animal ( Figure 3B -C) but revealed minor amounts of 25-HC (0.005 ± 0.002 -0.023 ± 0.034 ng/mm 2 ) and 24R-HC (0.004 ± 0.002 -0.023 ± 0.001 ng/mm 2 , Figure S4B , see also Figure S9 ). Although there was some variation in absolute concentrations in different mice, 24R-HC was at highest concentration in the cerebellum of each mouse ( Figure 5C , see also Supplemental Table  S2 ), 25-HC was more ubiquitously dispersed ( Figure S8 and Supplemental Table S1 ). Both of these oxysterols were detected at low levels in an earlier study of homogenised Cyp46a1-/-mouse brain, as was an unknown hydroxycholesterol eluting later than the second peak of 24R-HC. Here we again observe low levels of this oxysterol (0.007 ± 0.005 -0.012 ± 0.006 ng/mm 2 ) which we have previously assigned, based on retention time and MS 3 spectra, to be 12α-hydroxycholesterol (12α-HC, Figure S9 ) [Griffiths 2019 ]. Careful interrogation of the MS 3 spectra recorded prior to the elution of 25-HC indicate the presence of not only trace quantities of 24S-HC (detected but not quantified, Figure S9A ), but also of the elusive 20S-HC [Roberg-Larsen 2014]. 20S-HC gives a unique MS 3 spectrum where the fragment-ion m/z 327.2 is abundant ( Figure S9A, B & G) . By generating an MRM chromatogram for the transition m/z 539.4→455.4→327.2 this oxysterol is highlighted, although appearing as a shoulder on the leading edge of the 25-HC peak in the RIC for the [M] + ion ( Figure 9A ).
When the authentic standard of [ 2 H0]GP-derivatised 20S-HC was spotted on mouse brain tissue it eluted with an identical retention time to the [ 2 H5]GP derivatised endogenous molecule and the MS 3 spectra of the standard and endogenous molecule were very similar. There were some small differences in the spectra as a consequence of the co-elution of isomeric oxysterols from tissue. However, an intense fragment-ion at m/z 327.2 is unique to 20S-HC. 20S-HC has previously been reported to be present in rat brain and human placenta [Lin 2003 ]. Here we confirm it presence also in mouse brain and provide its approximate quantification.
2. 3.2. 7α, 7α,(25R)26-Dihydroxycholesterol (7α,26-diHC, cholest-5-ene-3β,7α(25R)26-triol) and 7α,(25R)26dihydroxycholest-4-en-3-one (7α,26-diHCO) represent potential precursors of 7αhydroxycholestenoic acids in brain (Supplemental Figure S1 ). Although the current LC gradient was not optimised with these two oxysterols in mind, their presence is defined by appropriate chromatographic peaks and by MS 3 spectra consistent with their structures ( Figure S10 ). However, the additional presence of 7α,24S-dihydroxy and 7α,25-dihydroxy isomers and of the 7α,(25S)26dihydroxy epimers, not separating from the 7α,(25R)26-dihydroxy isomer in the current system, cannot be ruled out. The levels of the dihydroxysterols are low in brain (0.001 ± 0.001 -0.004 ± 0.004 ng/mm 2 , Figure S10 A & B) .
3β,7α-diHCA and 7αH,3O-CA
The combined areal densities of 3β,7α-diHCA and 7αH,3O-CA can be measured more accurately than either of the individual species. As with the WT mice, the combined acids were consistently most abundant in the grey matter of the cerebellum of the Cyp46a1-/-mice (0.013 ± 0.014 ng/mm 2 , Figure  S8 , see also Figure S10 C -F), although again there was some mouse to mouse variation in areal density.
Cholesterol and its Precursors in WT Mouse Brain
Earlier studies have shown that the cholesterol content of whole brain does not differ significantly between WT and Cyp46a1-/-animals [Lund 2003 , Mast 2017b this was explained by a reduction of cholesterol synthesis compensating for reduced metabolism in the Cyp46a1-/-animals.
In the current study focus was on oxysterols rather than on cholesterol and its precursors. Never-theless, it was possible to make approximate measurements for cholesterol and the sum of its precursors 7-DHC and desmosterol. For more precise and accurate measurements, it will be necessary to optimise the chromatography to separate the latter isomers and to reduce tailing of highly abundant cholesterol (Supplemental Figure S4A ). Levels of cholesterol were of the order of 350 -820 ng/mm 2 and of 7-DHC plus desmosterol 2 -4 ng/mm 2 . No statistically significant differences were found in areal densities between WT and Cyp46a1-/-brain regions. Cholest-4-en-3-one has been found to be present in brain of Alzheimer's disease sufferers and at lower levels in control brain samples [Puglielli 2005 ]. Here we detect cholest-4-ene-3-one in all regions of mouse brain at areal densities in the region of 0.15 -0.32 ng/mm 2 in both WT and Cyp46a1-/-animals.
Application of MALDI-MSI for Cholesterol Analysis
As an alternative to µLESA-nano-LC-MS for the MSI of cholesterol we have explored the possibility of exploiting MALDI-MSI. Using on-tissue EADSA in a similar manner to that employed with µLESA, it was possible to image the [M] + ion of GP-derivatised cholesterol ( Figure 6 ).
Discussion
In the current work we have defined a methodology for the MSI of oxysterols in mouse brain using EADSA and µLESA-nano-LC-MS. This method compliments MALDI-MSI methods, also based on EADSA, being concurrently developed for cholesterol and its precursors in our laboratory. The major oxysterol in brain is 24S-HC [Björkhem 2006 [Björkhem , 2013 . Here we find it to be most abundant in the striatum and thalamus and least abundant in the cerebellum. 24S-HC is formed from cholesterol by the enzyme CYP46A1 expressed in neurons localised to multiple sub-regions of brain [Lund 1999 ]. In most studies, 24S-HC is analysed in whole brain homogenates being found at concentrations of 20 -60 ng/mg. Our values of 0.183 -1.752 ng/mm translate to 18 -171 ng/mg assuming efficient extraction from the 10 µm thick tissue sections and nimimal desiccation during tissue storage.
Cholesterol is the most abundant sterol in brain, being about 10 3 more abundant that 24S-HC. In the absence of derivatisation, or chelation with Ag + , cholesterol is barely detectable in most MSI experiments [Spengler 2015], and to date oxysterols, with the exception of 7-OC [Cobice 2013] , and cholestenoic acids have not been imaged in brain. However, following EADSA, cholesterol provides the most abundant signal in MSI experiment of brain tissue ( Figure 3A ) and 24S-HC is clearly defined at areal densities of low ng/mm 2 by µLESA-nano-LC-MS ( Figure 3B ). The sensitivity of the system extends down to areal densities below 0.01 ng/mm 2 , at which levels dihydroxysterols and cholestenoic acids are found (Supplemental Table S1 ).
The spatial resolution and spot size available with the µLESA format (400 µm spot diameter), is considerably inferior to that available with MALDI-MSI (50 µm laser spot diameter). However, µLESA can be coupled with LC, offering isomer separation, essential for oxysterol analysis of tissue surface, where resolution of endogenous oxysterols from those generated ex vivo by oxidation in air is required. MALDI can be linked with ion-mobility separation and MSI, but in experiments performed to date we have been unable to separate different oxysterol isomers. A disadvantage with the µLESAnano-LC-MS format adopted here is chromatographic run time, with each spot taking approximately 1 hr to analyse. This could be reduced by increasing LC flow-rate and column diameter from a nanoscale to a more conventional scale, where 15 min run times are more typical [Karu 2007 . However, increased flow-rate will come with the penalty of reduced sensitivity, due to the concentration dependency of ESI. This is unlikely to be an issue for 24S-HC but may well be for less abundant oxysterols.
It is interesting to compare the distribution of the most abundant oxysterols and cholestenoic acids measured here with the expression of genes coding for their biosynthetic enzymes, as detailed in the Allen Mouse Brain Atlas [Lein 2007 ]. According the Allen Mouse Brain Atlas the expression Cyp46a1, coding cholesterol 24S-hydroxylase, is highest in striatum and thalamus and lowest in cerebellum, which reflects the patterns of 24S-HC abundance measured here [Lein 2007 ] (see also Supplemental references). The gene Cyp27a1 coding the enzyme required to introduce a hydroxy and then carboxylate group at C-26 of cholesterol was of highest expression in the cerebellum [Lein 2007 ], which is in agreement with data generated here, finding cholestenoic acids to be most abundant in cerebellum.
24S-HC is by far the most abundant oxysterol in mouse brain , Mast 2017b , Griffiths 2019 . This makes analysis of low abundance isomers challenging. However, deletion of Cyp46a1 removes the biosynthesis of 24S-HC almost completely, allowing measurement of closely eluting or low abundance isomers ]. In the current study we were able to image 24R-HC, the epimer of 24S-HC, which is found to be of most abundance in cerebellum and to detect other isomers 12α-HC, 25-HC and the elusive 20S-HC. 22R-HC was also detected but at levels below the limit of quantification. The enzymes required to biosynthesise 24R-HC and 20S-HC from cholesterol are unknown. The abundance of 24R-HC in cerebellum of the Cyp46a1-/-mouse does suggest CYP27A1 to be the relevant cholesterol hydroxylase, but this is unlikely as 24R-HC is present in brain of the Cyp27a1-/-mouse [Griffiths 2019] . CYP3A11 is also a sterol 24R-hydroxylase and could perhaps convert cholesterol to 24R-HC in brain. It is however, predominantly expressed in cortex [Lein 2007 ]. CYP11A1 is the cholesterol 22R-hydroxylase required for neurosteroid biosynthesis and has been shown to be expressed in mouse brain [Chiang 2011 ]. It first hydroxylates cholesterol at position C-22R then at C-20, then cleaves the bond between these two carbons to generate pregnenolone. Besides being the enzyme responsible to generate 22R-HC from cholesterol, it may also be the catalyst for formation of 20S-HC from cholesterol, although evidence for this suggestion is lacking. There is only one previous report of the identification of 20S-HC in rodents or human [Lin 2003 ]. However, 20S-HC is of considerable biological interest being a ligand to the G protein-coupled receptor (GPCR) smoothened (SMO), an integral receptor protein in the hedgehog (Hh) signalling pathway, important for determining cell fate during development [Dwyer 2007 , Nachtergaele 2012 , Nedelcu 2013 ].
In summary, application of EADSA with LESA-µLESA-nano-LC-MSI allows spatial location of oxysterols and cholestenoic acids in mouse brain. Through exploitation of the Cyp46a1-/-, where the biosynthesis of 24S-HC is almost completely eliminated, other minor oxysterols are revealed. To compliment EADSA-µLESA-nano-LC-MSI we are developing EADSA in combination with MALDI-MSI. We find this ideal for imaging cholesterol at high spatial resolution.
Material and Methods
Common Experimental Design
The objective of the current study was to develop a MSI method suitable for the low-level quantitative determination of different oxysterols, including cholestenoic acids, in different regions of mouse brain.
Chemicals and Reagents
HPLC grade methanol and water were from Fisher Scientific (Loughborough, UK). Glacial acetic and formic acids were purchased from VWR (Lutterworth, UK). [25, 26, 26, 26, 27, 27, H7]22Shydroxycholesterol ([ 2 H7]22S-HC, [25, 26, 26, 26, 27, 27, H7]cholest-5-ene-3β,22S-diol), [25, 26, 26, 26, 27, 27, H7]22R-hydroxycholesterol ([ 2 H7]22R-HC, [25, 26, 26, 26, 27, 27, H7]cholest-5-ene-3β,22R-diol), [25, 26, 26, 26, 27, 27, H7]24R/S-hydroxycholesterol ([ 2 H7]24R/S-HC, [25, 26, 26, 26, 27, 27, H7]cholest-5-ene-3β,24R/S-diol) and [25, 26, 26, 26, 27, 27, H7]cholesterol were from Avanti Polar Lipids (Alabaster, AL). [25, 26, 26, 26, 27, 27, H7]22S-hydroxycholest-4-en-3one ([ 2 H7]22S-HCO) and [25, 26, 26, 26, 27, 27, 
Tissue Sectioning
Mouse brain was from male 4-month-old Cyp46a1-/-and wild type (WT Cyp46a1+/+, C57BL/6J;129S6/SvEv) littermates as detailed in [Mast 2017b ]. Fresh frozen tissue, mounted in OCT (optimal cutting temperature compound), was cryo-sectioned using a Leica Cryostat CM1900 (Leica Microsystems, Milton Keynes, UK) at a chamber temperature of -16ᵒC into 10 µm-thick sections which were thaw-mounted onto glass microscope slides and stored at -80ᵒC until use. Luxol Fast Blue and Cresyl Violet staining was performed on tissue sections adjacent to sections analysed by MSI. For MALDI-MS, ITO (indium tin oxide) coated glass slides were from Diamond Coatings (Halesowen, UK).
Deposition of Internal Standard and On-Tissue EADSA
Frozen tissue sections were dried in a vacuum desiccator for 15 min after which an internal standard mixture of [ 2 H7]24R/S-HC (5 ng/µL), [ 2 H7]22S-HC (1 ng/µL), [ 2 H7]22S-HCO (1 ng/µL), and in some experiments [ 2 H7]22R-HCO (1 ng/µL), in ethanol were sprayed from a SunCollect automated pneumatic sprayer (SunChrom, Friedrichsdorf, Germany supplied by KR Analytical Ltd, Cheshire, UK) at a flow rate of 20 µL/min at a linear velocity of 900 mm/min with 2 mm line distance and Z position of 30 mm in a series of 18 layers. The resulting density of the deuterated standard were, 1 ng/mm 2 for 24R/S-HC, and 0.2 ng/mm 2 for each of [ 2 H7]22S-HC, [ 2 H7]22S-HCO and [ 2 H7]22R-HCO (see Supplemental Methods 2.1.1.). The sprayer was thoroughly flushed with about 2 mL of methanol after which cholesterol oxidase (0.264 units/mL in 50 mM KH2PO4 pH7) was sprayed for 18 layers. The first layer was applied at 10 µL/min, the second at 15 µL/min, then all the subsequent layers at 20 µL/min to give an enzyme density of 0.05 munits/mm 2 . Thereafter, the enzyme-coated slide was placed on a flat dry bed in a sealed pipette-tip box (11.9 cm x 8.2 cm x 8.5 cm) above 30 mL of warm water (37 o C), then incubated at 37ᵒC for 1 hr. After which, the slide was removed and dried in a vacuum desiccator for 15 mins. [ 2 H5]GP (6.3 mg/mL in 70% methanol with 5% acetic acid) was sprayed on the dried slide with the same spray parameters as used for spraying cholesterol oxidase. The resulting GP density was 1.21 µg/mm 2 . The slide was then placed on a flat dry table in a covered glass chamber (12 cm x 12 cm x 7.2 cm) containing 30 mL of pre-warmed (37 o C) 50% methanol, 5% acetic acid and incubated in a water bath at 37ᵒC for 1 hr. The slide was removed and dried in a vacuum desiccator until nano-LC-MS analysis. To analyse sterols containing a naturally occurring oxo group the cholesterol oxidase spray step was omitted and [ 2 H0]GP (5 mg/mL in 70% methanol with 5% acetic acid) used as the derivatisation agent.
For MALDI-MSI experiments the above procedure was slightly modified as described in Supplemental Methods 2.2.
µLESA-nano-LC-MSI
Robotic µLESA
Derivatised oxysterols present in 10 µm thick slices of brain tissue were sampled using a TriVersa Nanomate (Advion, Ithaca, NY) with a modified capillary extraction probe (LESA PLUS ). The Advion ChipsoftX software was used to capture an optical image of the prepared slide on a flatbed scanner prior to analysis. The same software was also used to define extraction points on the tissue prior to analysis. A 330 µm i.d. / 794 µm o.d. FEP (a copolymer of hexafluoropropylene and tetrafluoroethylene) sleeve was attached to a 200 µm i.d. / 360 µm o.d. fused silica capillary held in the mandrel of the Advion TriVersa Nanomate, this created a seal when in contact with tissue preventing the dispersion of extraction solvent (50% methanol) and limiting the sampling area to the internal diameter of the FEP sleeve (see Supplemental Figure S3 ).
Three µL of extraction solvent was aspirated into the capillary from the solvent reservoir (R3 -R4 in Figure 2 ), the mandrel moved robotically to an exact tissue location and 1 µL of solvent dispensed ontissue and held for 30 s before being aspirated back into the capillary. The mandrel moved once again, and the extract was dispensed into a well of a 384-well plate. The process was repeated twice more with extract dispensed into the same well, before the combined extract was injected via the extraction probe into the sample loop of the nano-LC system (see below). The entire procedure was then repeated on a new extraction point. Multiple points were analysed to build up an oxysterol image of brain tissue.
Nano-LC-MS(MS n )
Nano-LC separations were performed on an Ultimate 3000 UHPLC system (Dionex, now Thermo Scientific, Hemel Hempstead, UK). The µLESA extract was delivered from the sample loop onto a trap column (HotSep Tracy C8, 5 µm 100 Å, 5 mm x 0.3 mm, Kinesis Ltd, Bedfordshire, UK) using a loading solvent of 50% methanol, 0.1% formic acid at a flow-rate of 5 µL/min. The eluent from the trap column containing unreacted GP reagent was delivered to waste (Figure 2) . After 13 min the trap column was switched in-line with the analytical column (ACE C18, 3 µm 100 Å, 100 mm x 0.1 mm, Aberdeen, Scotland) and a gradient delivered by the binary nanopump at 0.6 µL/min. Mobile phase A consisted of 50% methanol, 0.1% formic acid and mobile phase B consisted of 95% methanol, 0.1% formic acid. At 13 min, the time of valve switching, the proportion of B was 40 %, and was raised to 60% B over the next 5 min and maintained at 60% B for 5 min, then raised again to 95% B over 5 min and maintained at 95% B for a further 38 min before being reduced to 20% B in 1 min (run time 67 min) and the column re-equilibrated for 11 min. The trap-column was switched out of line at 67 min and re-equilibrated for 11 min with 50% methanol, 0.1% formic acid prior to the next injection (Supplemental Figure 3C) . The column eluent was directly infused into an Orbitrap Elite mass spectrometer (Thermo Scientific, Hemel Hempstead, UK) using the Nanomate chip-based nano-ESI (Advion, Ithaca, NY) set at between 1.7 kV and 2.0 kV chip voltage. To avoid cross-contamination between samples a column wash with injection of 10 µL of 100% propan-2-ol and a fast gradient of 36 min was performed between injections of tissue extracts. The 100% propan-2-ol "plug" was delivered to the trap column and washed for 5 min before being switched in-line with the analytical column, which during this period was washed independently by raising the proportion of B from 20% to 95%. With the two columns in-line the proportion of B was maintained at 95% B 19 min after which it returned to 20% within 1 min. The trap column was then switched off-line and both columns equilibrated for a further 11 min before the next sample was injected. The gradients are illustrated in Supplemental Figure S3 .
For each injection five scan events were performed: one high resolution scan (240,000 full-width at half maximum height definition at m/z 400) in the Orbitrap analyser in parallel to four MS 3 scan events in the linear ion-trap. Quantification was by isotope dilution using tissue-coated isotope-labelled standard. MS 3 scans were for the transitions [M] + →[M-Py] + →, where Py is the pyridine group of the GP-derivative.
Quantification
To achieve reliable quantitative measurements known amounts of isotope labelled internal standard [ 2 H7]24R/S-HC (for use with cholesterol oxidase) and [ 2 H7]22S-HCO (for use in the absence of cholesterol oxidase) were sprayed on-tissue prior to the EADSA process. This procedure corrects for variation in surface extraction, injection volume, and MS response. Quantification was made from Figure S9G ).
Statistics
One-way ANOVA, followed by Tukey's corrected multiple comparisons test with a single pooled variance, were performed to determine statistical difference of sterol areal densities between different regions of mouse brain using GraphPad Prism 7.02 software (GraphPad Software, Inc, CA, USA). A P-value of less than 0.05 was considered statistically significant. P<0.05, *; P<0.01, **; P<0.001, ***; P<0.0001. Whiskers on bar graphs represent standard deviation (SD). Figure 2 . Schematic representation of the of the µLESA system linked to with nano-LC. With connections between ports 1 and 6 and between 3 and 2, the 6-port injection valve is in the load position. Once loaded, connections are made between ports 4 and 3 and between 6 and 5. Sample is transported to the 10-port valve and with connections made between ports 8 and 9 and 2 and 3 (on the 10-port valve), sterols are trapped on the C8 trap-column. Port 1 is then connected to 2, 9 to 10 and sterols eluted from the trap column to the analytical nano-LC column. Figure S4A is the RIC for the [M] + ion of cholesterol (m/z 523.4419 ± 10 ppm, WT mouse upper panel) and for monohydroxycholesterols (m/z 539.4368 ± 10 ppm, WT mouse central panel, Cyp46a1-/-mouse lower panel), including cholesterol autoxidation products, from the striatum. The ex vivo autoxidation products elute considerably later than endogenous side-chain hydroxycholesterols. All three panels are shown on the same y-axis Figure 4 . Sagittal section of WT mouse brain analysed by µLESA-nano-LC-MS following EADSA treatment. (A) Areal density of 24S-HC in four nearby sagittal slices cut from a single brain. (B) Areal density of 24S-HC in six nearby slices cut from three different brains. Slices were taken from the right hemisphere 1 -2 mm away from the midsagittal line. The number of spots analysed for each region of each brain slice is indicated by numbers within the bars. %CV is shown above the bars for each region. (C) The Table shows values for areal density, across the six slices for the three mice (WT-1 -WT-3) and nine different brain regions. Average areal density and SD is calculated from data for the six slices. Data is converted into ng/mg-brain based on a brain-mass/area ratio of 0.0102 mg/mm 2 for a typical brain slice. (D) Images of the sagittal section of WT mouse brain analysed by µLESA-nano-LC-MS. The top panel shows a photograph of a tissue slice from WT mouse brain showing spots analysed with areal density, determined by µLESA-nano-LC-MS, of 24S-HC colour coded on a blue to red scale. The lower panel shows a Luxol Fast Blue and Cresyl Violet stained brain slice, adjacent to the slice analysed by µLESA-nano-LC-MS, with areal density of 24S-HC colour coded as in the upper panel. Figure 5 . Sagittal section of mouse brain analysed by µLESA-nano-LC-MS following EADSA treatment. (A) Areal density of 24S-HC in the nine brain regions from the three WT mice. (B) Areal density for the combination of 3β,7α-diHCA and 7αH,3O-CA in the nine brain regions from the three WT mice. (C) Areal density of 24R-HC in the nine different brain regions from three Cyp46a1-/-mice. Statistical differences between the nine regions for the three biological replicates are indicated. The number of spots analysed for each brain region is indicated within the bars. 
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